XML 61 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Variable Interest Entity (Tables)
12 Months Ended
Dec. 31, 2016
Variable Interest Entity  
Schedule of DOSE's financial information included in the accompanying financial statements:

 

Consolidation of DOSE’s results of operations included the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended

 

 

 

December 31, 

 

 

 

2016

 

2015

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general & administrative

    

$

 —

    

$

105

    

$

243

 

Research and development

 

 

 —

 

 

890

 

 

1,557

 

Interest expense

 

 

 —

 

 

85

 

 

156

 

Net loss of DOSE

 

$

 —

 

$

1,080

 

$

1,956

 

 

Consolidation of DOSE’s cash flows included the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended

 

 

 

December 31,

 

 

 

2016

 

2015

 

2014

 

 

 

 

 

 

 

 

 

 

 

 

Cash used in operating activities

    

$

 —

    

$

(1,134)

    

$

(1,271)

 

Cash used in investing activities

 

 

 —

 

 

(33)

 

 

(39)

 

Cash provided by financing activities

 

 

 —

 

 

1,158

 

 

1,315

 

(Decrease) increase in cash and cash equivalents of DOSE

 

$

 —

 

$

(9)

 

$

5